Listed

Techprecision Corp: Form 10-Q for the period ended Dec 31, 2021

Filed with the SEC on Feb 17, 2022 and accepted by EDGAR at Feb 17, 2022, 16:17 ET.

Share

Management's discussion and analysis

As filed, 36,388 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Statement Regarding Forward Looking Disclosure

The following discussion of the results of our operations and financial condition should be read in conjunction with our condensed consolidated financial statements and the related notes, which appear elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q, including this section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” may contain predictive or “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained in this quarterly report, including statements that express our intentions, plans, objectives, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “should,” “would” and similar expressions, as they relate to us, are intended to identify forward-looking statements.

These statements are based on current expectations, estimates and projections made by management about our business, our industry and other conditions affecting our financial condition, results of operations or business prospects. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, the forward-looking statements due to numerous risks and uncertainties. Factors that could cause such outcomes and results to differ include, but are not limited to risks and uncertainties arising from:

  • our reliance on individual purchase orders, rather than long-term contracts, to generate revenue;
  • our ability to balance the composition of our revenues and effectively control operating expenses;
  • external factors, including the COVID-19 pandemic, that may be outside of our control;
  • the impacts of the COVID-19 pandemic and government-imposed lockdowns in response thereto;
  • the availability of appropriate financing facilities impacting our operations, financial condition and/or liquidity;
  • our ability to receive contract awards through competitive bidding processes;
  • our ability to maintain standards to enable us to manufacture products to exacting specifications;
  • our ability to enter new markets for our services;
  • our reliance on a small number of customers for a significant percentage of our business;
  • competitive pressures in the markets we serve;
  • changes in the availability or cost of raw materials and energy for our production facilities;
  • restrictions in our ability to operate our business due to our outstanding indebtedness;
  • government regulations and requirements;
  • pricing and business development difficulties;
  • changes in government spending on national defense;
  • our ability to make acquisitions and successfully integrate those acquisitions with our business;
  • general industry and market conditions and growth rates;
  • our potential failure to successfully integrate and realize the expected benefits of the Stadco acquisition;
  • unexpected costs, charges or expenses resulting from the acquisition and integration of Stadco; and
  • those risks discussed in “Item 1A. Risk Factors” and elsewhere in our Annual Report on Form 10-K, as well as those described in any other filings which we make with the SEC.

Any forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this Quarterly Report on Form 10-Q, except as required by applicable law. Investors should evaluate any statements made by us in light of these important factors.

Overview

Contract Manufacturing

Through our Ranor and Stadco subsidiaries, we offer a full range of services required to transform raw materials into precision finished products. Our manufacturing capabilities include: fabrication operations (cutting, press and roll forming, assembly, welding, heat treating, blasting and painting) and machining operations including CNC (computer numerical controlled) horizontal and vertical milling centers. We also provide support services to our manufacturing capabilities: manufacturing engineering (planning, fixture and tooling development, manufacturing), quality control (inspection and testing), materials procurement, production control (scheduling, project management and expediting) and final assembly.

All manufacturing is done in accordance with our written quality assurance program, which meets specific national and international codes, standards, and specifications. The standards used are specific to the customers’ needs, and our manufacturing operations are conducted in accordance with these standards.

Because our revenues are derived from the sale of goods manufactured pursuant to contracts, and we do not sell from inventory, it is necessary for us to constantly seek new contracts. There may be a time lag between our completion of one contract and commencement of work on another contract. During such periods, we may continue to incur overhead expense but with lower revenue resulting in lower operating margins. Furthermore, changes in either the scope of an existing contract or related delivery schedules may impact the revenue we receive under the contract and the allocation of manpower. Although we provide manufacturing services for large governmental programs, we usually do not work directly for the government or its agencies. Rather, we perform our services for large governmental contractors. Our business is dependent in part on the continuation of governmental programs that require our services and products.

Our contracts are generated both through negotiation with the customer and from bids made pursuant to a request for proposal. Our ability to receive contract awards is dependent upon the contracting party’s perception of such factors as our ability to perform on time, our history of performance, including quality, our financial condition and our ability to price our services competitively. Although some of our contracts contemplate the manufacture of one or a limited number of units, we continue to seek more long-term projects with predictable cost structures.

On August 25, 2021, the Company completed its previously announced acquisition of Stadco, a company in the business of manufacturing high-precision parts, assemblies and tooling for aerospace, defense, research and commercial customers. We believe that the Stadco operation fits our primary defense focus and brings a complementary customer list for our defense and industrial markets.

Financial Results

Our results of operations are affected by a number of external factors including the availability of raw materials, commodity prices (particularly steel), macroeconomic factors, including the availability of capital that may be needed by our customers, and political, regulatory and legal conditions in the United States and in foreign markets. Generally, our projects are made up of contracts with a production timeline that can range from three to as much as thirty-six months. Units manufactured under the majority of our customer contracts are delivered on time and with a positive gross margin. Our results of operations for any specific period are also affected by our success in booking new contracts, the timing of revenue recognition, delays in customer acceptances of our products, delays in deliveries of ordered products and our rate of progress fulfilling obligations under our contracts. A delay in deliveries or cancellations of orders could have an unfavorable impact on liquidity, cause us to have inventories in excess of our short-term needs, and delay our ability to recognize, or prevent us from recognizing, revenue on contracts in our order backlog.

For the three months ended December 31, 2021, we recorded net sales and net loss of $6.5 million and $0.9 million, compared with net sales of $3.6 million and net loss of $48,172, for the three months ended December 31, 2020. For the nine months ended December 31, 2021, we recorded net sales and net income of $14.7 million and $0.2 million, compared with net sales of $11.6 million and net income of $0.1 million, for the nine months ended December 31, 2020. Our financial statements for the three and nine months ended December 31, 2021 include the results of the Stadco operation from August 26, 2021 through December 31, 2021.

On May 12, 2021, as authorized by Section 1106 of the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, the Small Business Administration, or the SBA, remitted to Berkshire Bank, the lender of record, a payment of principal and interest in the amount of $1,317,100 and $13,207, respectively, for forgiveness of the Company’s Paycheck Protection Program loan, or PPP loan. Funds credited to the bank paid this loan off in full. Loan forgiveness is recorded as a gain in the condensed consolidated statement of operations.

Critical Accounting Estimates

The preparation of the condensed consolidated financial statements requires that we make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We continually evaluate our estimates, including those related to business combinations, revenue recognition, inventories, recovery of long-lived assets, income taxes and the valuation of equity transactions. These estimates and assumptions require management’s most difficult, subjective or complex judgments. Actual results may vary under different assumptions or conditions.

We consider the principles and estimates applied for revenue recognition to be one of the most critical accounting estimates that we make. Our revenue can fluctuate from quarter-to-quarter as we measure revenue recognition over the duration of a project, or at the end of the project. The Company records most of its revenue over time as it completes performance obligations or at a point-in-time, for example, at the delivery date, when control of the promised goods are transferred to the customer. Project volume for revenue recognized at a point-in-time is generally smaller, can fluctuate from period to period, and is difficult to forecast.

We measure progress for performance obligations satisfied over time using input methods, for example, labor hours expended and time elapsed. As a result, assuming a steady flow of project volume and labor hours, we have the ability to deliver a fair and accurate flow of revenue over time. When project volume is higher or lower, we may report higher or lower amounts of revenue for those given quarterly periods.

Our significant accounting policies are set forth in detail in Note 2 to the consolidated financial statements included in the 2021 Annual Report on Form 10-K. Except for the addition of our Goodwill policy, there were no significant changes to our critical accounting policies during the nine months ended December 31, 2021.

New Accounting Standards

See Note 15, Accounting Standards Update, in the Notes to the condensed consolidated financial statements in “Item 1. Financial Statements” for a discussion of recently adopted new accounting guidance.

Key Performance Indicators

While we prepare our financial statements in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, we also utilize and present certain financial measures that are not based on or included in U.S. GAAP. We refer to these as Non-GAAP financial measures. Please see the section “EBITDA Non-GAAP financial measure” below for further discussion of these financial measures, including the reasons why we use such financial measures and reconciliations of such financial measures to the most directly comparable U.S. GAAP financial measures.

Results of Operations

Three Months Ended December 31, 2021 and 2020

The following table sets forth information from our condensed consolidated statements of operations and comprehensive income (loss), in dollars and as a percentage of revenue:

(dollars in thousands)

​ ​ ​ ​ ​ ​ ​ ​ Three months ended December 31, 2021 Amount ​ ​ ​ ​ Percent ​ ​ 2020 Amount ​ ​ ​ ​ ​ Percent ​ ​ ​ ​ Changes Amount ​ ​ ​ ​ ​ ​ ​ Percent ​
Net sales $6,511 100% $3,569 100% $2,942 ​ 82%
Cost of sales ​ 6,033 93% 2,864 80% 3,169 ​ 111%
Gross profit ​ 478 7% 705 20% (227) ​ (32)%
Selling, general and administrative ​ 1,624 25% 716 20% 908 ​ 127%
Operating loss ​ (1,146) (18)% (11) —% (1,135) ​ nm%
Other expense, net ​ (93) (1)% (50) (1)% (43) ​ (86)%
Loss before taxes ​ (1,239) (19)% (61) (2)% (1,178) ​ nm%
Income tax (benefit) expense ​ (334) (5)% (13) (1)% (321) ​ nm%
Net loss ​ $(905) (14)% $(48) (1)% $(857) ​ nm%

nm - not meaningful

Net Sales

Changes in net sales generally reflect a different product mix and project volume when comparing the current and prior periods. For the three months ended December 31, 2021, changes in net sales were also significantly affected by the addition of revenue from our Stadco subsidiary acquired in August 2021. Net sales were $6.5 million for the three months ended December 31, 2021, or 82% higher when compared to net sales for the three months ended December 31, 2020.

Our defense backlog remains strong as new orders for components continue to flow down from prime defense contractors in connection with the U.S. Navy submarine programs, and new customers from our recent Stadco business acquisition. For the three months ended December 31, 2021, net sales to our defense markets increased by $3.5 million or 120% when compared to the three months ended December 31, 2020. The primary reason for the increase were new defense sales recorded for the first time with new customers from our recent Stadco business acquisition which accounted for approximately 57% of our net sales to defense industry customers during the three months ended December 31, 2021. With our recent Stadco business acquisition now complete, we anticipate reporting higher revenues in future quarters.

Net sales to industrial markets decreased by $0.5 million, or 78%, when compared to the three months December 31, 2020, due to lower project activity as the Company replenishes its industrial market backlog following a period of above-normal revenue for the last three quarters of fiscal 2021. We have repeat business in this sector, but the order flow can be uneven and difficult to forecast.

For the three months ended December 31, 2021, revenue recognized over time and at a point in time was $6.4 and $0.1 million, respectively, compared to revenue recognized over time and at a point in time of $3.1 and $0.4 million, respectively, for the three months ended December 31, 2020.

Cost of Sales and Gross Margin

Cost of sales consists primarily of raw materials, parts, labor, overhead and subcontracting costs. Our cost of sales for the three months ended December 31, 2021 was $6.0 million, or 111% higher when compared to the three months ended December 31, 2020. Gross margin was 7.3% for the three months ended December 31, 2021 and 19.8% for the three months ended December 31, 2020. Gross profit was $0.5 million for the three months ended December 31, 2021, or 32% lower, when compared to the three months ended December 31, 2020, primarily the result of higher labor and overhead costs.

This is the first quarterly period that includes the operations of our Stadco business for the entire quarterly period. We also recorded higher labor costs and under-absorbed factory overhead during the third quarter because of a lower number of available production hours due to calendar year-end scheduling. This led to a slower changeover from completed projects to new projects and resulted in an unfavorable production mix that depressed profit margins for the third quarter. We expect an improvement with our production mix in the final quarter of fiscal 2022.

Selling, General and Administrative Expenses

Total selling, general and administrative expenses for the three months ended December 31, 2021 increased by 127%, or $0.9 million. The increase was primarily due to the inclusion of Stadco operations for the entire quarterly period ($0.5 million) and an increase in outside advisory fees ($0.3 million) in connection with the Stadco acquisition. Other travel expense and office costs ($0.1 million) made up the balance of the increase.

Other Expense, net

The following table reflects interest expense, amortization of debt issue costs and other income, net for the three months ended:

​ ​ ​ ​ ​ December 31, 2021 ​ ​ ​ December 31, 2020 ​ ​ ​ $ Change ​ ​ ​ % Change
Other income, net ​ $1,999 ​ $(219) ​ $2,218 nm ​
Interest expense ​ $(78,230) ​ $(36,391) ​ $(41,839) (115)%
Amortization of debt issue costs ​ $(16,491) ​ $(14,014) ​ $(2,477) (18)%

Interest expense was higher for the three months ended December 31, 2021. The increase in interest expense for the three months ended December 31, 2021 was due primarily to $37,520 of interest expense under the new Stadco term loan, and $9,901 of interest expense on amounts borrowed under the revolver loan. We may record higher interest expense in future periods due to the borrowings under our new Berkshire revolver and term loans.

Amortization of debt issue costs for the three months ended December 31, 2021 increased due to higher debt issue costs incurred for new loans.

Income Taxes

For the three months ended December 31, 2021 we recorded a tax benefit of $333,867 compared with tax benefit of $13,369 for the three months ended December 31, 2020.

Net (Loss) Income

As a result of the foregoing, for the three months ended December 31, 2021, we recorded a net loss of $904,680 compared to a net loss of $48,172 for the three months ended December 31, 2020.

Nine Months Ended December 31, 2021 and 2020

The following table sets forth information from our condensed consolidated statements of operations and comprehensive income, in dollars and as a percentage of revenue:

(dollars in thousands)

​ ​ ​ ​ ​ ​ ​ ​ Nine Months Ended December 31, 2021 Amount ​ ​ ​ ​ Percent ​ ​ 2020 Amount ​ ​ ​ ​ ​ Percent ​ ​ ​ ​ Changes Amount ​ ​ ​ ​ ​ ​ Percent ​
Net sales ​ $14,721 100% $11,566 100% $3,155 27%
Cost of sales ​ 12,480 85% 9,035 78% 3,445 38%
Gross profit ​ 2,241 15% 2,531 22% (290) (11)%
Selling, general and administrative ​ 3,530 24% 2,206 19% 1,324 60%
Operating (loss) income ​ (1,289) (9)% 325 3% (1,614) (497)%
Other expense, net ​ (168) (1)% (159) (1)% (9) (6)%
PPP loan forgiveness ​ 1,317 9% — —% 1,317 nm%
(Loss) income before taxes ​ (140) (1)% 166 2% 306 (184)%
Income tax (benefit) expense ​ (386) (3)% 60 1% (446) (743)%
Net income ​ $246 2% $106 1% $140 131%

nm - not meaningful

Net Sales

Changes in net sales generally reflect a different product mix and project volume when comparing the current and prior periods. Net sales were $14.7 million for the nine months ended December 31, 2021, or 27% higher when compared to net sales for the nine months ended December 31, 2020.

Our defense backlog remains strong as new orders for components continue to flow down from prime defense contractors in connection with the U.S. Navy submarine programs, and new customers from our recent Stadco business acquisition. For the nine months ended December 31, 2021, net sales in our defense markets increased by $4.6 million or 49% when compared to the nine months ended December 31, 2020. The primary reason for the increase were new defense sales recorded for the first time by our Stadco subsidiary since August 25, 2021 which accounted for approximately 34% of our net sales to defense industry customers during the nine months ended December 31, 2021. With our recent Stadco acquisition now complete, we anticipate higher revenues in fiscal 2022.

Net sales to industrial markets decreased by $1.4 million, or 62% when compared to the nine months ended December 31, 2020, due to lower project activity as the Company replenishes its industrial market backlog following a period of above normal revenue for the last three quarters of fiscal 2021. We have repeat business in this sector, but the order flow can be uneven and difficult to forecast.

For the nine months ended December 31, 2021, revenue recognized over time and at a point in time was $13.3 and $1.5 million, respectively, compared to revenue recognized over time and at a point in time of $9.3 and $2.3 million, respectively, for the nine months ended December 31, 2020.

Remaining performance obligations reflect future revenue that will be recorded in subsequent periods as projects in progress are completed. At December 31, 2021, the Company had $35.2 million of remaining performance obligations, of which $22.3 million were less than 50% complete. The Company expects to recognize all of its remaining performance obligations as revenue within the next thirty-six months.

Cost of Sales and Gross Margin

Cost of sales consists primarily of raw materials, parts, labor, overhead and subcontracting costs. Our manufacturing operations continued to run normally during the period, albeit with higher cost of sales which dampened gross margin for the first nine months of fiscal 2022, as we brought our new Stadco operation on-line in the month of September.

Our cost of sales for the nine months ended December 31, 2021 was $12.5 million, higher by 38% when compared to the nine months ended December 31, 2020, primarily the result of higher labor and overhead costs which more than offset lower material costs. Gross margin was 15.2% for the nine months ended December 31, 2021 and 21.9% for the nine months ended December 31, 2020. Gross profit for the nine month periods ended December 31, 2021 and 2020 was $2.2 million and $2.5 million, respectively.

We have experienced a period of slowly rising labor costs and under absorbed overhead since the first month of the fiscal year which was amplified by an unfavorable production mix as discussed in our third quarter results. This set of conditions has put pressure on our gross margins. We expect an improvement with our production mix in the final quarter of fiscal 2022.

Selling, General and Administrative Expenses

Total selling, general and administrative expenses for the three months ended December 31, 2021 increased by $1.3 million, or 60%. The increase was primarily due to the inclusion of Stadco operations since August 25, 2021 ($0.6 million) and an increase in outside advisory fees ($0.5 million) in connection with the Stadco acquisition. Increase in travel expenses and other office costs ($0.2 million) made up the balance of the increase.

Other Expense, net

The following table reflects interest expense, amortization of debt issue costs and other income, net for the nine months ended:

​ ​ ​ ​ ​ December 31, 2021 ​ ​ ​ December 31, 2020 ​ ​ ​ $ Change ​ ​ ​ % Change
Other income, net ​ $13,390 ​ $1,237 ​ $12,153 nm ​
Interest expense ​ $(146,906) ​ $(114,786) ​ $(32,120) (28)%
Amortization of debt issue costs ​ $(34,588) ​ $(45,099) ​ $10,511 23%

nm – not meaningful

Other income for the nine months ended December 31, 2021 includes a return of $10,000 for a retainer fee previously paid for outside advisory fees in connection with a class action settlement in March 2021.

Interest expense was higher for the nine months ended December 31, 2021. The increase in interest expense was due primarily to new borrowings under the new Stadco term loan and amounts outstanding under the revolver loan. During the prior-year period, there were no borrowings outstanding under the revolver loan. We expect to record higher interest expense in future periods due to the higher debt load under our new term loan and revolver loan.

Amortization of debt issue costs were higher in the nine months ended December 31, 2020 due to higher closing costs in connection with modifications to the Berkshire loans in 2020.

PPP Loan Forgiveness

On May 12, 2021, as authorized by Section 1106 of the CARES Act, the SBA remitted to Berkshire Bank, the lender of record, a payment of principal in the amount of $1,317,100, for forgiveness of the Company’s PPP loan. The funds credited to the PPP loan paid this loan off in full.

Income Taxes

For the nine months ended December 31, 2021 we recorded a tax benefit of $385,749, compared to a tax provision of $60,573 for the nine months ended December 31, 2020. The tax benefit is the result of operating pretax losses. The gain from the forgiveness of the Company’s PPP loan is a discrete nontaxable event.

Net Income

As a result of the foregoing, for the nine months ended December 31, 2021, we recorded net income of $0.2 million compared to net income of $0.1 million for the nine months December 31, 2020.

Liquidity and Capital Resources

At December 31, 2021, we had cash and cash equivalents of $0.6 million and working capital of $3.1 million, a decrease when compared to March 31, 2021. We believe our available cash, plus cash expected to be provided by operations and borrowing capacity available under the revolver loan, will be sufficient to fund our operations, expected capital expenditures, and principal and interest payments under our debt obligations through the next 12 months from the issuance date of our financial statements. Our revolver loan matures in December 2022 and will not be available to provide liquidity unless it is renewed.

On August 25, 2021, we completed the acquisition of Stadco, closed on a private placement financing and closed on a new loan with Berkshire Bank. In connection with the acquisition, we raised $3.5 million of cash by selling 3,202,727 shares of common stock at $1.10 per share via a private placement financing, sourced $4.0 million in new debt with Berkshire bank, drew down $0.1 million under the revolver loan and sourced $1.8 million from available cash. We issued 1.5 million shares of our common stock and warrants to satisfy Stadco’s indebtedness to its shareholders and certain other debt holders and acquired all outstanding shares of Stadco.

In addition, we purchased Stadco’s loan from Sunflower Bank, for a total amount of $7.9 million in cash. Concurrent with the closing of the Stadco acquisition, we entered into an amended and restated loan agreement with Berkshire Bank. Under the amended facility, our term loan in the original principal amount of $2.85 million, of which $2.4 million remains outstanding, will remain, and we will have access to a revolving line of credit of up to $5.0 million, and borrowed $4.0 million under a new term loan with Berkshire bank.

There was $2.0 million outstanding under the revolver loan at December 31, 2021. There were no borrowed amounts outstanding under the revolver loan at March 31, 2021. Unused borrowing capacity at December 31, 2021 was approximately $2.1 million. The maturity date of the revolver loan is December 20, 2022.

There is a balloon payment of approximately $2.4 million due in March 2022 under the Ranor term loan with Berkshire Bank. We expect to refinance this debt with the bank before the maturity date. Until then, the Company will continue to pay down principal and make interest payments in the ordinary course.

In addition to the cash commitments required under our financing arrangements with Berkshire Bank, we also anticipate that we will spend approximately $0.8 million in new factory machinery and equipment during the remainder of fiscal 2022.

The table below presents selected liquidity and capital measures at:

(dollars in thousands)

​ ​ ​ ​ ​ ​ ​ ​ December 31, 2021 ​ ​ ​ ​ ​ ​ March 31, 2021 ​ ​ ​ ​ Change Amount
Cash and cash equivalents ​ $562 ​ $2,131 ​ $(1,569)
Working capital ​ $3,096 ​ $5,202 ​ $(2,106)
Total debt ​ $8,201 ​ $3,829 ​ $4,372
Lease liabilities ​ $6,567 ​ $— ​ $(6,567)
Total stockholders’ equity ​ $15,830 ​ $9,942 ​ $5,888

The following table summarizes the primary components of cash flows for the nine months ended:

(dollars in thousands)

​ ​ Cash flows provided by (used in): ​ ​ ​ ​ ​ ​ December 31, 2021 ​ ​ ​ ​ ​ ​ ​ December 31, 2020 ​ ​ ​ ​ ​ Change Amount ​
Operating activities ​ $(1,649) ​ $(340) ​ $(1,309)
Investing activities ​ (8,232) ​ (547) ​ (7,685)
Financing activities ​ 8,313 ​ 1,211 ​ 7,102
Net (decrease) increase in cash and cash equivalents ​ $(1,568) ​ $324 ​ $(1,892)

Operating activities

Apart from our loan facilities, our primary sources of cash are from accounts receivable collections, customer advance payments and project progress payments. Our customers make advance payments and progress payments under the terms of each manufacturing contract. Our cash flows can fluctuate significantly from period to period as we mark progress with customer projects and the composition of our receivables collections mix changes between advance payments and customer payments made after shipment of finished goods.

Cash used in operating activities for the nine months ended December 31, 2021 was $1.7 million. Cash outlays for the nine months ended December 31, 2021 includes a payment of $0.5 million to plaintiffs for a court approved final class action settlement, and $0.7 million of cash used to pay past due rent on the Stadco property and buildings.

Overall, the first nine months of fiscal 2022 was marked by favorable project performance progress and delivery schedules. However, throughput slowed on certain projects during the third quarter as fewer hours were available due to calendar year end holiday schedules. Customers have been invoiced for these projects and others started in December 2021, so we anticipate higher available cash balances after January 1, 2022.

We used $0.3 million of cash in operating activities during the first nine months of fiscal 2021, as accounts receivable and contract assets increased and contract liabilities decreased due to a changing production mix.

Investing activities

We anticipate that we will spend approximately $0.8 million in new factory machinery and equipment during the remainder of fiscal 2022. Net cash used in investing activities for purchases of property, plant and equipment in the nine months ended December 31, 2021 was $0.4 million. In addition, we purchased Stadco’s outstanding debt from Sunflower Bank, for $7.9 million in cash.

Financing activities

We sourced $3.5 million of cash by selling 3,202,727 shares of common stock at $1.10 per share via a private placement financing and $4.0 million in new debt with Berkshire bank. In addition we drew down $2.6 million under the revolver loan used to fund the acquisition and operating activities since August 25, 2021 and repaid $0.6 million in the third quarter of fiscal 2022.

We used $0.5 million of cash to make periodic lease payments and pay off certain lease and debt obligations. We also used $0.7 million of cash to pay private placement closing costs, debt issue costs, and repay debt principal.

All of the above activity resulted in a net decrease in cash of $1.6 million for the nine months ended December 31, 2021 compared with a net increase in cash of $0.3 million for the nine months ended December 31, 2020.

Small Business Administration PPP Loan

On May 8, 2020, the Company, through its wholly owned subsidiary Ranor, Inc., issued a promissory note evidencing an unsecured PPP loan in the amount of $1,317,100 made to Ranor under the CARES Act. The PPP loan to Ranor was made through Berkshire Bank.

Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of loans granted under the PPP, with such forgiveness to be determined, subject to limitations, based on the use of the loan proceeds for payment of payroll costs, certain group health care benefits and insurance premiums, and any payments of mortgage interest, rent, and utilities.

The Company applied for loan forgiveness with the SBA under the Paycheck Protection Program on March 26, 2021. On May 12, 2021, as authorized by Section 1106 of the CARES Act, the SBA remitted to Berkshire Bank, the lender of record, a payment of principal and interest in the amount of $1,317,100 and $13,207, respectively, for forgiveness of the Company’s PPP loan. The funds credited to the PPP loan paid this loan off in full. Loan forgiveness is recorded as a gain under other income and expense in the condensed consolidated statement of operations.

EBITDA Non-GAAP Financial Measure

To complement our condensed consolidated statements of operations and comprehensive (loss) income and condensed consolidated statements of cash flows, we use EBITDA, a non-GAAP financial measure. Net (loss) income is the financial measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to EBITDA. We believe EBITDA provides our board of directors, management and investors with a helpful measure for comparing our operating performance with the performance of other companies that have different financing and capital structures or tax rates. We also believe that EBITDA is a measure frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry, and is a measure contained in our debt covenants. However, while we consider EBITDA to be an important measure of operating performance, EBITDA and other non-GAAP financial measures have limitations, and investors should not consider them in isolation or as a substitute for analysis of our results as reported under GAAP.

We define EBITDA as net (loss) income plus interest, income taxes, depreciation and amortization. The following table provides a reconciliation of EBITDA to net (loss) income, the most directly comparable GAAP measure reported in our condensed consolidated financial statements for the following periods:

(dollars in thousands)

​ ​ ​ ​ ​ ​ Three Months ended December 31, 2021 ​ ​ ​ 2020 ​ ​ ​ Change ​ ​ ​ Nine Months ended December 31, 2021 ​ ​ ​ 2020 ​ ​ ​ Change
Net (loss) income ​ $(905) ​ $(48) ​ $(857) ​ $246 ​ $106 ​ $140
Income tax (benefit) expense ​ (334) ​ (13) ​ (321) ​ (386) ​ 61 ​ (447)
Interest expense (1) ​ 95 ​ 50 ​ 45 ​ 181 ​ 160 ​ 21
Depreciation and amortization ​ 463 ​ 182 ​ 281 ​ 979 ​ 521 ​ 458
EBITDA ​ $(681) ​ $171 ​ $(852) ​ $1,020 ​ $848 ​ $172

(1) Includes amortization of debt issue costs.

Controls and procedures

As filed, 3,858 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures.

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are controls and procedures that are designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and includes controls and procedures designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

As of the end of the period covered by this report, an evaluation was carried out, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December 31, 2021, our disclosure controls and procedures were effective at a reasonable assurance level.

Inherent Limitations over Internal Controls

The Company’s internal control over financial reporting is designed under the supervision of our Chief Executive Officer and Chief Financial Officer, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that the Company’s receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Management, including the Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods is subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Changes in Internal Control over Financial Reporting

For the quarter ended December 31, 2021, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting. The Company continues to evaluate Stadco’s internal controls over financial reporting and integrating such with its own internal controls over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2021-10-01 to 2021-12-31$6.0mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2021-04-01 to 2021-12-31$12.5mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2021-10-01 to 2021-12-31$478.1kus-gaap:GrossProfit
Gross profit9 months2021-04-01 to 2021-12-31$2.2mus-gaap:GrossProfit
Selling, general and administrative3 months2021-10-01 to 2021-12-31$1.6mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2021-04-01 to 2021-12-31$3.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-10-01 to 2021-12-31−$1.1mus-gaap:OperatingIncomeLoss
Operating income9 months2021-04-01 to 2021-12-31−$1.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-10-01 to 2021-12-31$94.7kus-gaap:InterestExpense
Interest expense9 months2021-04-01 to 2021-12-31$181.5kus-gaap:InterestExpense
Income tax3 months2021-10-01 to 2021-12-31−$333.9kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2021-04-01 to 2021-12-31−$385.7kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-10-01 to 2021-12-31−$904.7kus-gaap:NetIncomeLoss
Net income9 months2021-04-01 to 2021-12-31$246.0kus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2021-10-01 to 2021-12-31−$0.03us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2021-04-01 to 2021-12-31$0.01us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-10-01 to 2021-12-31−$0.03us-gaap:EarningsPerShareBasic
Basic EPS9 months2021-04-01 to 2021-12-31$0.01us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-10-01 to 2021-12-3134,286,580 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2021-04-01 to 2021-12-3133,395,123 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2021-04-01 to 2021-12-31−$1.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2021-04-01 to 2021-12-31$436.5kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-12-31$562.5kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-12-31$15.4mus-gaap:AssetsCurrent
Total assetsAt period end2021-12-31$37.4mus-gaap:Assets
Current liabilitiesAt period end2021-12-31$12.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-12-31$21.6mus-gaap:Liabilities
Long-term debtAt period end2021-12-31$3.2mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2021-12-31$15.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001410578-22-000163. Last ingested by Listed: Nov 10, 2026, 04:27 ET. Listed shows no prices and gives no investment advice.